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Abstract
Schizotypy is a multidimensional personality construct that is characterized by perceptual
abnormalities, social withdrawal, mild suspiciousness, and odd thinking patterns. This study
examined the relationship between four dimensions of self-reported schizotypy and substance
use involving nicotine, alcohol, and cannabis, in undergraduate students. Results showed that
higher levels of disorganized schizotypy, or odd thinking and behavior, were associated with
greater indices of use of all three substances. Furthermore, higher cognitive-perceptual
schizotypy was selectively associated with cannabis use. Results confirm findings of recent
research that has discovered associations among schizotypy and substance use, highlighting links
between behavioral traits and use of nicotine, alcohol, and cannabis. This study is one of the first
to examine a wide range of schizotypy domains, and to show selective effects of the disorganized
domain of schizotypy.

Key Words: Alcohol; Cannabis; Nicotine; Schizotypal Personality Questionnaire; Schizotypy;
Substance abuse

3

1.0 Introduction
Schizotypy is a multifaceted personality profile of great interest to personality and
schizophrenia researchers alike. The schizotypy construct encompasses a set of dimensional
traits in behavioral, perceptual, ideational, cognitive, and affective domains that exist along
continua in the general population (Raine, Lencz, & Mednick, 1995). Biological relatives of
individuals with schizophrenia are more likely to exhibit schizotypal traits than those without a
family history of the illness (Kendler, McGuire, Gruenberg, & Walsh, 1995), suggesting that
schizotypy is genetically related to schizophrenia. Individuals with schizotypal personality
features exhibit social deficits similar to, but less prominent than, those found in schizophrenia
(Dickey et al., 2005).
Investigators have long been interested in the high prevalence of substance use in
individuals with schizophrenia, given that up to 50% of individuals with schizophrenia have a
co-occurring substance use disorder (Dixon, 1999). In light of the relationship between
schizophrenia and schizotypy, lines of investigation have more recently turned toward examining
associations between schizotypy and substance use. Some research in the general population has
shown that greater levels of schizotypy are related to cigarette, alcohol, and cannabis use.
Regarding the use of cigarettes, Allan and colleagues (1995) found a positive correlation
between self-reported schizotypy and a measure of the number of cigarettes smoked per day.
Other studies have revealed similar results (Joseph, Manafi, Iakovaki, & Cooper, 2003; Larrison,
Briand, & Sereno, 1999; Wiles et al., 2006). A recent study in this area of research examined the
relationship between cigarette use and schizotypy in a sample of healthy adults and relatives of
patients with schizophrenia (Esterberg, Jones, Compton, & Walker, 2008). Individuals who
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smoked had greater levels of schizotypy; however, the relationship was significant only among
the relatives of patients with schizophrenia.
Schizotypy has also been examined in relation to use of alcohol. Rather than a global
positive relationship between the two, results suggest a more nuanced pattern of associations
between alcohol use and specific domains of schizotypy. Nunn and colleagues (2001), for
example, found that alcohol use in a sample of undergraduate students was related to lower
introvertive anhedonia, or negative schizotypy, and to higher scores on delusional conviction, a
construct similar to positive schizotypy. Larrison et al. (1999) found that increased alcohol use
was associated with lower scores on the Rust Inventory of Schizotypal Cognitions (RISC; Rust,
1998), a measure of positive schizotypy. There have been nNo other published studies
conducted that have examined the relationship between schizotypy and alcohol use in the general
population.
An emerging body of research suggests an association between schizotypy and cannabis
use (Compton, Goulding, & Walker, 2007). Several studies involving university students have
demonstrated correlations between cannabis use and positive schizotypal symptomatology in
particular (Bailey & Swallow, 2004; Dumas et al., 2002; Mass, Bardong, Kindl, & Dahme, 2001;
Nunn, Rizza, & Peters, 2001; Schiffman, Nakamura, Earleywine, & LaBrie, 2005; Skosnik,
Krishnan, Aydt, Kuhlenshmidt, & O’Donnell, 2006). One study found a significant positive
correlation between schizotypy scores and total self-reported years of cannabis use (Skosnik et
al., 2006), and another showed that in individuals reporting cannabis use, average age of onset of
schizotypal symptoms preceded the age of initiation of cannabis use (Schiffman et al., 2005).
Bailey and Swallow (2004) found a broader set of associations between cannabis use and the
presence of positive, negative, and disorganized schizotypal characteristics among 60
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undergraduates. However, some studies have suggested that individuals who use cannabis have
lower negative schizotypal symptomatology than those not using the drug (Nunn et al., 2001;
Schiffman et al., 2005).
Given the relative dearth of literature that has examined the relationship between
schizotypy and substance use in large non-psychiatric samples, and the importance of emerging
research in this area, this study examined associations between four domains of self-reported
schizotypy (cognitive-perceptual, paranoid, negative, and disorganized) and the use of nonprescription substances of abuse (nicotine, alcohol, and cannabis) in a non-psychiatric sample of
undergraduate college students at a large, urban university. This study attempted to elucidate
Comment [EM1]: “Potentially drive” felt too
causal to me. I

how personality factors such as schizotypy potentially drivepredict substance use behaviors,
which has important implications for public health theory. Understanding more about the
predictors of substance use is vital for the development of prevention and treatment efforts,
especially in light of recent research that has shown that interventions targeting personality
factors significantly reduce use of substances such as alcohol (Conrod, Castellanos, & Mackie,
2008).
2.0 Method
2.1 Participants
Participants consisted of a non-clinical sample (n=950) of undergraduate college students
enrolled in classes at an urban state university in the southeastern United States. Students
enrolled in introductory psychology classes from January 2007 to December 2007 were eligible
for participation. Only those students between the ages of 18 and 26 years who spent at least 20
minutes completing the survey were included in the analyses, resulting in a final sample size of
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n=825. Not all participants completed all measures; therefore, the total number of participants
included in the different analyses varied across statistical tests.
2.2 Procedure
Students were invited to participate via a recruitment statement on an experiment
management system, which is an online program used to manage the undergraduate research
pool at the university. Interested students were required to read an IRB-approved online consent
form before proceeding to the questionnaire, which implied their consent to participate.
Participants anonymously completed a confidential, web-based survey, and received course
credit in return for participation. Automated data entry produced computerized survey data files
for data cleaning and data analysis.
2.3 Measures
The Schizotypal Personality Questionnaire (SPQ; Raine, 1991) is a 74-item self-report
measure that is modeled on the nine criteria of schizotypal personality disorder as defined by the
Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. The SPQ total
scale score ranges from 0 to 74, given that each positively endorsed item counts one point. A
confirmatory factor analysis (Compton, Goulding, McClure-Tone, & Bakeman, 2008) of the nine
SPQ subscales with the sample in the current investigation revealed a best-fit model of four
factors: cognitive-perceptual (odd beliefs and perceptual abnormalities); paranoid (ideas of
reference, suspiciousness, and excessive social anxiety); negative (suspiciousness, excessive
social anxiety, and constricted affect); and disorganized (eccentric behavior and odd speech).
These four factors were used in all analyses.
Participants were also asked to provide information about their substance use histories
with regard to three substances: nicotine (cigarette smoking), alcohol, and cannabis. For each
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substance, they were asked: (1) whether or not they had ever used the substance (i.e., lifetime
use); (2) if so, their age in years at first use; (3) whether or not they had used the substance in the
past 90 days; and (4) if so, the average number of days (range=0–7) per week they had used the
substance in the past 90 days. Individuals who reported lifetime use of cigarettes, alcohol, or
cannabis were included in subsequent analyses with respect to their age at first use of the
substance, whether or not they had used in the past 90 days, and their average daily use of the
substance in the past 90 days.
2.4 Data Analysis
The relationships among the four factors of the SPQ and the substance use variables were
examined using linear and logistic regression analyses, with age and sex included as covariates
as appropriate, based on preliminary correlation analyses and t-tests. The four factors of the SPQ
served as predictors of substance use, and each of the substance use variables served as
dependent variables; this resulted in a total of twelve regression analyses. To limit the number of
statistical analyses performed, the four factors of the SPQ were entered into one step of each
regression model. Although the four SPQ subscales were moderately correlated, the large
sample size and a subsequent examination of variance inflation factors, tolerance statistics, and
confidence interval widths for each of the regression models safeguarded against the effects of
potential multicollinearity.
3.0 Results
Table 1 provides sociodemographic characteristics of the sample as well as details
regarding schizotypy and substance use. The average age of participants was 20.1 ± 1.7 years,
and over three-quarters (637, 77.2%) were female. The large percentage of females was
attributed to participants being recruited from an undergraduate introductory psychology course,
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in which the majority of students tend to be female. Nearly half of the students (383, 46.4%)
self-identified as White/Caucasian, 254 (30.8%) as Black/African American, 84 (10.2%) as
Asian American, and 104 (12.6%) as of other races. The mean scores for the total SPQ,
cognitive-perceptual, paranoid, negative, and disorganized factors were 22.98 ± 13.61 (range =
0–74), 3.95 ± 3.41 (range=0–16), 9.77 ± 5.60 (range=0–25), 9.94 ± 6.80 (range=0–33), and 5.26
± 4.07 (range=0–16), respectively.
In preliminary analyses, relationships between several demographic characteristics and
the substance use variables were examined. Student’s t-tests indicated that participants who
reported lifetime use of cigarettes, alcohol, or cannabis, as well as use of alcohol or cannabis
Comment [EM2]: I think it would be useful, if
space permits, to include the stats here or at least t’s
and p values. This goes for the whole paragraph.

during the past 90 days, were more likely to be older than non-users. Pearson product moment
correlations showed that age was also positively correlated with age at first use of alcohol and
cannabis, as well as with average number of days per week that alcohol was used during the past
90 days. T-test results indicated that substance use differed between the sexes as well.
Specifically, males were more likely than females to have used cannabis in the past 90 days, and
to have used cannabis more frequently during the past 90 days. Given these findings, age and
sex were entered as covariates in the regression models predicting substance use.
Preliminary analyses also examined the correlations and relationships within the four
schizotypy domains and within among the substance use variables (Tables 2 and 3). As
expected, these results showed moderate to large correlations among the four schizotypy
domains as well as the twelve variables of substance use, with most relationships being
statistically significant. However, as previously mentioned, the large sample size assisted in
controlling for multicollinearity, although additional drug use was not controlled for during

Comment [EM3]: This sentence isn’t clear to me.
It sounds as if you’re saying 2 conflicting things: 1)
we worried less about multicollinearity because of
the large sample, and 2) we didn’t include drugs as
covariates for each other for fear of losing power.
These seem to be 2 separate ideas—I suggest
breaking this into 2 sentences.

analyses of the effects on each individual drug to avoid removal of statistical effects.
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A logistic regression revealed that a model containing all four factors of the SPQ
significantly predicted lifetime use of cigarettes (Table 4). However, only the disorganized
factor of the SPQ was a significant independent predictor, such that higher levels of disorganized
schizotypy were predictive of ever having smoked. A separate logistic regression showed that a
model containing all four factors also significantly predicted use of cigarettes in the past 90 days;
the disorganized factor was a significant predictor. Again, higher scores on the disorganized
factor significantly predicted cigarette use during the past 90 days. A linear regression revealed
that a model containing the four SPQ factors did not significantly predict age at first use of
cigarettes (Table 4). Finally, a separate linear regression showed that a model containing the
four SPQ factors significantly predicted average daily use of cigarettes over the past 90 days,
explaining 2% of the variance above and beyond age and sex. Within the model, only the
disorganized factor was a significant individual predictor. Again, higher scores on the
disorganized factor predicted greater average daily use of cigarettes.
A logistic regression revealed that a model including all four schizotypy domains did not
significantly predict lifetime use of alcohol (Table 5); however, within the model, the
disorganized schizotypy factor was a significant individual predictor. A separate logistic
regression showed a model including all four factors also did not significantly predict use of
alcohol in the past 90 days. However, the disorganized factor was individually predictive of
alcohol use during the past 90 days. A linear regression revealed that a model with all four
schizotypy factors did not significantly predict age at first use of alcohol, explaining only 1% of
the variance (Table 5). Finally, a separate linear regression showed that a model including the
four schizotypy domains significantly predicted average daily use of alcohol over the past 90
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days, explaining 4% of the variance. The disorganized factor was again a significant individual
predictor, with greater disorganization predicting greater average daily use of alcohol.
Lastly, a logistic regression revealed that a model containing all four factors of the SPQ
significantly predicted lifetime use of cannabis (Table 6). The disorganized factor of the SPQ
was a significant individual predictor, such that higher levels of disorganized schizotypy were
predictive of ever having used cannabis. A separate logistic regression showed that a model
containing all four factors also significantly predicted cannabis use in the past 90 days; the
disorganized factor was again a significant individual predictor. Similar to the effects seen
regarding use of cigarettes and alcohol, higher scores on the disorganized factor significantly
predicted cannabis use during the past 90 days. A linear regression revealed that a model
containing the four SPQ factors did not significantly predict age at first use of cannabis (Table
6), explaining only 2% of the variance, and there were no significant individual predictors.
Finally, a separate linear regression showed that a model containing the four SPQ factors
significantly predicted average daily use of cannabis over the past 90 days, explaining 3% of the
variance. Both the cognitive-perceptual and disorganized factors were significant individual
predictors. Higher scores on both factors predicted greater average daily use of cannabis.
4.0 Discussion
This study provided descriptive information regarding various domains of schizotypy and
substance use behaviors in a sample of undergraduate university students. Results showed that
the overall level of schizotypy in this sample was comparable to that found in other normative
samples that have included individuals of all ages, with studies reporting an average total SPQ
score of around 24 (Hall & Habbits, 1996; Raine, 1991). Furthermore, results on rates of
substance use in this sample showed rates of use that awere similar to those reported by the most
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recent National Survey on Drug Use and Health for individuals ages 12 and older (SAMHSA,
2008). However, use of cannabis in the past 90 days was slightly higher, at 22.4% of the sample,
compared to 14.4% reporting use in the past month on the national health survey.
Results from the current analyses indicate that the disorganized factor of the SPQ had a
significant and widespread association with substance use in this sample, such that higher
disorganized schizotypy predicted greater likelihood of using substances and younger age at
onset of substance use. Results also showed that the cognitive-perceptual factor had selective
associations with substance use in this sample, such that it was significantly related to the use of
cannabis. There was no evidence that the paranoid and negative factors had any relationship
with use of any of the substances. However, with respect to the differential impact of various
domains on particular substances, these findings should be interpreted with caution given the
moderate correlations between use of nicotine, alcohol, and cannabis.
Regarding nicotine, past research has shown that individuals who smoke cigarettes report
higher levels of schizotypy than do individuals who do not smoke (Allan et al., 1995; Joseph et
al., 2003; Larrison et al., 1999; Wiles et al., 2006). The current study examined four domains of
schizotypy rather than a total composite score including all domains, and results showed that
individuals with higher disorganized schizotypy were more likely to report lifetime use of
cigarettes, to have used cigarettes during the past 90 days, and to have used cigarettes more
frequently during the past 90 days. Esterberg et al. (2008) also found that individuals who
smoked cigarettes had higher scores on the disorganized factor of the SPQ; however, this
relationship was only significant in relatives of patients with schizophrenia and not in nonpsychiatric adult controls. Although the current study did not collect information on
participants’ family history of mental illness, it is the first to reveal a relationship between a
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specific domain of schizotypy, namely disorganized schizotypy, and cigarette smoking in a nonpsychiatric sample.
Levels of disorganized schizotypy in this undergraduate sample also predicted lifetime
use of alcohol, use of alcohol in the past 90 days, and greater average daily use of alcohol during
the past 90 days. Past research has found alcohol use to relate to lower scores on measures of
negative schizotypy (Nunn et al., 2001), delusional conviction, and positive schizotypy (Larrison
et al., 1999). This is likely related to the social nature of alcohol use, especially in undergraduate
populations. Those higher in positive and negative schizotypy may be less likely to participate in
social situations that involve alcohol use, due to the unusual thoughts, anhedonia, and social
withdrawal that these individuals typically experience. Contrary to these past studies, positive
(i.e., cognitive-perceptual) and negative forms of schizotypy were not related to use of alcohol in
the present sample. However, the current study is the first to suggest a potential relationship
between greater disorganized schizotypy and alcohol use in a non-psychiatric sample of young
adults.
Finally, regarding cannabis use, the cognitive-perceptual and the disorganized factors
were significantly related to use of this substance. Most past research has revealed significant
relationships between positive schizotypy and cannabis use (Compton et al., 2007; Schiffman et
al., 2005; Skosnik et al., 2006). Mass et al. (2001) found, in a sample of university students,
higher levels of schizotypy as measured by the SPQ in individuals who used cannabis. The
findings of the current study replicate the association between positive schizotypy and cannabis
use that has been found in previous research, though the cognitive-perceptual domain was only
significantly associated with one of four measures of cannabis use, namely the average number
of days used per week during the past 90 days. Furthermore, the findings herein are similar to
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the results of Bailey and Swallow (2004), who discovered a positive association between
disorganized schizotypy and cannabis use in a small sample of undergraduates.
In general, the fairly consistent association between the disorganized dimension of the
SPQ and substance use was somewhat unexpected. Items in the odd or eccentric behavior
subscale of the disorganized domain include: “Other people see me as slightly eccentric (odd),”
and “People sometimes comment on my unusual mannerisms and habits.” Items in the odd
speech subscale of the disorganized domain include: “People sometimes find it hard to
understand what I am saying.” There are several potential explanations for this relationship
between disorganized schizotypy and substance use. First, it could be that participants who
engage in more frequent substance use are more likely to experience more frequent intoxication,
which can manifest as behaviors that approximate disorganized schizotypy. For example,
participants who are frequently intoxicated may understandably receive feedback from others
describing them as odd or difficult to understand. Therefore, participants may be rating the
effects of substance use rather than actual schizotypy.
Second, those participants who have high levels of schizotypy may be more likely to
engage in substance use given as a function of their odd or eccentric behavior. SuchGiven this
behavior, may lead these individuals are likelyto appear strange to others, and it is hypothesized
that these characteristics might lead to greater social anxiety. This social anxiety may influence
individuals high in disorganized schizotypy to engage in substance use to alleviate the stress
experienced in social situations. Finally, the link between disorganized schizotypy and substance
use could potentially be explained by a relationship between the underlying neurobiology of
subtle disorganization and the neurobiology of addictive behaviors.
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Several methodological limitations, inherent to the study design, should be considered.
First, inferences about causality should be avoided given the cross-sectional nature of the study.
Second, the original factor structure of the SPQ included some overlap between the three
subscales; the factor structure used in the current study (i.e., four factors) also had some overlap,
such that the suspiciousness and excessive social anxiety subscales were included in both the
paranoid and the negative factors (Compton et al., 2008). Third, the measure of schizotypy was
based on self-report rather than researchers’ ratings, and it is possible that some aspects of
schizotypy may not be fully recognized by those who have such traits. Fourth, the study design
utilized a web-based survey, which has inherent limitations that should be acknowledged; for
example, lack of computer expertise could contribute to response errors.
Other limitations concern the generalizability of the current findings to the general
population. Given that the sample was comprisedYounger individuals, such as the of
undergraduate university students in this sample, it could be that younger individualscould
display greater variability than older adults in their substance use behaviors; . for For example,
college students may be more likely to engage in heavier or binge-type drinking behaviors. This

Comment [EM4]: If there’s a reference you could
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greater variability in substance use behaviors has implications for detecting relationships with
Comment [EM5]: I’m not sure I follow—it might
be clearer to specify more precisely what these
implications are. Is it that college-age binge drinking
may be a passing phase that is less closely tied to
personality than are more entrenched drinking
patterns? Clarifying exactly what you mean here
would be good.

other variables such as personality; therefore, these findings may not generalize to other
individuals who are not college students. Finally, given limited availability of comprehensive,
self-administered substance use measures, the current study utilized single-item measures of
substance use behavior, thus limiting our ability to conduct reliability and validity assessments.
Despite these limitations, this study is the first to examine multiple domains of
schizotypy in relation to the use of several different substances using a reliable and valid
measure of the multidimensional schizotypy construct. Furthermore, this study enrolled a large
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sample, a characteristic that previous research has often lacked. This not only allowed for a
robust investigation of different aspects of schizotypy, but also an examination of the
associations between these constructs and the use of three different substances. Future research
should attempt to include standardized measures of substance use to allow for comparisons
across studies, and to ensure the reliable measurement of substance use behaviors.
Other future directions for research in this area include longitudinally assessing both
schizotypy and substance use to inform causal models that address the potential reciprocal
effects of subclinical psychiatric symptoms on substance use in healthy individuals, as well as
how these two variables temporally relate to one another. It will be especially important to tease
apart various substances to determine the differential impact of domains of schizotypy on
different substances. Furthermore, given the relationship between schizotypy and schizophrenia
and the high prevalence of substance use in individuals with schizophrenia, future research
should attempt to examine the impact of family history of schizophrenia on the relationship
between schizotypy and substance use. Finally, given that this study highlighted important links
between personality variables and substance use, future research should focus on the importance
of personality factors in the prevention and treatment of substance use.
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Table 1. Sociodemographic, schizotypy, and substance use characteristics of sample (n = 825)
Characteristic

Mean ± SD

Range

Characteristic

(%)
Age
Sex (Female)

Mean ± SD

Range

(%)

20.1 ± 1.7

18 – 25.9

77.2%

--

Lifetime use of cigarettes

47.8%

--

Use of cigarettes in past 90 days (of

54.8%

--

those who have used)
Race (Caucasian)

46.4%

--

Age at first use of cigarettes

15.6 ± 2.7

6 – 23

Race (African American)

30.8%

--

Average days/week used cigarettes in

0.9 ± 2.2

0–7

Lifetime use of alcohol

81.1%

--

Use of alcohol in past 90 days (of those

79.7%

--

past 90 days
Race (Other)
SPQ Total

22.8%

--

22.9 ± 13.6

0 – 74

who have used)
SPQ Cognitive-perceptual

3.9 ± 3.4

0 – 16

Age at first use of alcohol

15.9 ± 2.5

2 – 22

SPQ Paranoid

9.8 ± 5.6

0 – 25

Average days/week used alcohol in past

1.2 ± 1.5

0–7

90 days
SPQ Negative

9.9 ± 6.8

0 – 33

Lifetime use of cannabis

42.1%

--

SPQ Disorganized

5.3 ± 4.1

0 – 16

Use of cannabis in past 90 days (of

53.3%

--

Age at first use of cannabis

16.3 ± 2.5

8 – 24

Average days/week used cannabis in

0.7 ± 1.7

0–7

those who have used)

past 90 days

22

Table 2. Intercorrelations among schizotypy domains
Schizotypy Domain

SPQ Cognitive-perceptual

SPQ Paranoid

SPQ Negative

SPQ Cognitive-perceptual
SPQ Paranoid

0.52*

SPQ Negative

0.43*

0.84*

SPQ Disorganized

0.55*

0.56*

0.58*

* Correlation significant at p < 0.001
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Table 3. Intercorrelations and chi-square values for relationships among substance use variables
Substance
Use Variable

1

2

3

4

1
2

1
2
3
4
5
6

0.02

-0.04

5

6

7

8

9

10

11

12

120.63**

-0.31**

103.43**

0.35**

247.89**

-0.22**

108.43**

0.29**

-0.08

0.41**

-0.03

-0.01

-0.08

0.60**

-0.08

-0.16*

3

0.02

39.35**

-0.19**

84.33**

0.34**

140.68**

-0.17*

111.31**

0.37**

4

-0.04

0.19**

-0.17**

0.25**

0.33**

0.39**

-0.19**

0.32**

0.39**

110.27**

-0.01

40.49**

0.17**

-0.29**

0.47**

-0.24**

-0.21**

136.92**

-0.09

104.21**

0.25**

0.42**

-0.12*

0.32**

0.36**

-0.12*

-0.26**

5

120.63**

-0.08

39.35**

0.19**

6

-0.31**

0.41**

-0.19**

-0.17**

7

103.43**

-0.03

84.33**

0.25**

-0.15**

8

-0.15**

-0.18**

0.35**

-0.01

0.34**

0.33**

-0.18**

9

247.89**

-0.08

140.68**

0.39**

110.27**

-0.29**

136.91**

0.42**

10

-0.22**

0.60**

-0.17**

-0.19**

-0.01

0.47**

-0.09

-0.12*

11

108.43**

-0.08

111.31**

0.32**

40.49**

-0.24**

104.21**

0.32**

-0.12*

12

0.29**

-0.16**

0.37**

0.39**

0.17**

-0.21**

0.25**

0.36**

-0.26**

Lifetime use of cigarettes
Age at first use of cigarettes
Used cigarettes in past 90 days
Average days per week used cigarettes
Lifetime use of alcohol
Age at first use of alcohol

7
8
9
10
11
12

Used alcohol in past 90 days
Average days per week used alcohol
Lifetime use of cannabis
Age at first use of cannabis
Used cannabis in past 90 days
Average days per week used cannabis

* Significant at p < 0.05
** Significant at p < 0.01
Bolded values represent chi-square values

24

Table 4. Results of linear and logistic regression analyses pertaining to four schizotypy domains and nicotine use
SPQ Domain1

Average days/week
Lifetime use

Used in past 90 days

Age at first use

used in past 90 days

n used= 394

n used = 216

Mean, 15.63 ± 2.66 years

Mean, 0.99 ± 2.18 days

χ² = 19.26*

χ² = 21.51*

R2 = 0.02

R2 = 0.02*

OR

CI

OR

CI

β

t

β

t

Cognitive-Perceptual

1.03

0.98 – 1.09

1.03

0.97 – 1.09

-0.01

-0.07

-0.02

-0.34

Paranoid

1.02

0.96 – 1.07

1.03

0.97 – 1.09

0.05

0.47

0.10

1.52

Negative

0.96

0.92 – 1.00

0.97

0.92 – 1.01

-0.04

-0.38

-0.12

-1.67

Disorganized

1.08*

1.03 – 1.14

1.09*

1.03 – 1.15

-0.14

-1.94

0.16

3.23*

1

SPQ domains entered into one step of the regression model

* Significant at p < 0.01
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Table 5. Results of linear and logistic regression analyses pertaining to four schizotypy domains and alcohol use
SPQ Domain1

Average days/week
Lifetime use

Used in past 90 days

Age at first use

used in past 90 days

n used = 669

n used = 533

Mean, 15.93 ± 2.49 years

Mean, 1.17 ± 1.45 days

χ² = 9.22

χ² = 7.59

R2 = 0.01

R2 = 0.04*

OR

CI

OR

CI

β

t

β

t

Cognitive-Perceptual

1.04

0.96 – 1.12

1.01

0.96 – 1.08

-0.03

-0.62

0.06

1.34

Paranoid

0.98

0.92 – 1.06

1.00

0.95 – 1.06

-0.09

-1.10

-0.09

-1.24

Negative

0.98

0.93 – 1.04

0.98

0.94 – 1.02

0.14

1.76

0.04

0.55

Disorganized

1.08*

1.01 – 1.16

1.06*

1.01 – 1.12

-0.09

-1.74

0.11

2.21*

1

SPQ domains entered into one step of the regression model

* Significant at p < 0.05
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Table 6. Results of linear and logistic regression analyses pertaining to four schizotypy domains and cannabis use
SPQ Domain1

Average days/week
Lifetime use

Used in past 90 days

Age at first use

used in past 90 days

n used = 347

n used = 185

Mean, 16.28 ± 2.07 years

Mean, 0.65 ± 1.70 days

χ² = 12.01*

χ² = 18.29**

R2 = 0.02

R2 = 0.03**

OR

CI

OR

CI

β

t

β

t

Cognitive-Perceptual

1.03

0.98 – 1.09

1.06

0.99 – 1.12

-0.04

-0.51

0.10

2.25*

Paranoid

1.00

0.95 – 1.06

1.01

0.96 – 1.08

0.05

0.50

0.02

0.30

Negative

0.99

0.95 – 1.03

0.97

0.93 – 1.02

0.01

0.10

-0.06

-0.90

Disorganized

1.06*

1.00 – 1.11

1.07*

1.01 – 1.13

-0.13

-1.80

0.11

2.26*

1

SPQ domains entered into one step of the regression model

* Significant at p < 0.05
** Significant at p < 0.01
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